AI channel feed

GSK ex­pands AI part­ner­ship with Tem­pus, fronting $70M for ac­cess to 'mul­ti­modal data'

3 years ago
Deals

Months af­ter adding $60M to cof­fers, AI start­up Ter­ray nabs dis­cov­ery pact with Google's Cal­i­co

3 years ago
Deals

Il­lu­mi­na con­tin­ues trek in­to drug dis­cov­ery, inks AI pact with As­traZeneca

3 years ago
Deals

An AI, err ma­chine learn­ing, shop lines up Eli Lil­ly as part­ner ahead of first in-house clin­i­cal tri­al

3 years ago
Deals
Pharma

Tout­ing nine-fig­ure deal pack­age, Pfiz­er ex­tends col­lab­o­ra­tion with AI part­ner

3 years ago
Pharma

No­vo Nordisk Foun­da­tion is­sues $200M grant to ap­ply quan­tum com­put­ing to life sci­ences, drug dis­cov­ery

3 years ago
Deals

Mi­crosoft sinks deep­er in­to drug AI, inks col­lab with di­a­betes gi­ant No­vo Nordisk

3 years ago
Deals

Ex­sci­en­tia ter­mi­nates Bay­er pact half a year ear­ly, col­lect­ing small por­tion of €240M promised

3 years ago
Deals

A cou­ple bil­lion for Ex­sci­en­tia was on­ly part of Sanofi's AI am­bi­tions, as the Big Phar­ma adds Atom­wise to the ta­ble

3 years ago
Deals

A new AI start­up, launched with a trio of Fred Hutch vets, wants to give a 'zoomed-in' view of can­cer cells

3 years ago
Financing

Up­dat­ed: Deep­Mind's Al­phaFold now con­tains struc­ture of 200M pro­teins. What does that mean for drug R&D?

3 years ago
R&D

As ALS pa­tients unite around Amy­lyx, a new pa­per hints at po­ten­tial drug­gable tar­gets

3 years ago
R&D
Discovery

MIT lab cre­ates tool to find can­cer mu­ta­tion dri­vers 'any­where in the genome'

3 years ago
Discovery

Ex­clu­sive: Pfiz­er vet grabs $25M seed round to 'in­te­grate' ma­chine learn­ing, ge­nomics tech in drug R&D

3 years ago
Financing
Startups

Fol­low­ing tie-up with Sanofi, transat­lantic AI firm se­cures lat­est Big Phar­ma deal in nine-fig­ure Bris­tol My­ers pact

3 years ago
Deals

No hu­mans al­lowed: Alex Zha­voronkov adds ro­bot­ic lab to his AI drug dis­cov­ery play as In­sil­i­co un­veils $60M raise

3 years ago
Financing

Is this Sil­i­con Val­ley duo the fu­ture of biotech?

4 years ago
People
In Focus

Genen­tech-part­nered Gen­e­sis Ther­a­peu­tics inks newest AI dis­cov­ery deal with Eli Lil­ly

4 years ago
Deals

Wait, what? Or­a­cle tech founder Lar­ry El­li­son in­vests in­to ex-stealth ge­nomics di­ag­nos­tics biotech

4 years ago
Diagnostics

Psych and neu­ro R&D notch a win as BioX­cel gets FDA ap­proval for schiz­o­phre­nia, bipo­lar dis­or­der-re­lat­ed ag­i­ta­tion

4 years ago
FDA+

Glax­o­SmithK­line keeps truck­ing along­side AI with new, mul­ti-year pathol­o­gy part­ner­ship with Boston out­fit

4 years ago
Deals

Con­cer­tAI sings a uni­corn tune as the FDA-part­nered clin­i­cal tri­als soft­ware up­start ex­pands

4 years ago
Financing

An AI biotech emerges from stealth promis­ing drugs 'on de­mand.' What will that look like, and is it even pos­si­ble?

4 years ago
Financing
Startups

Bio­phar­ma has hyped AI for years. But as the first tri­als get un­der­way, ex­perts try to man­age ex­pec­ta­tions

4 years ago
In Focus
First page Previous page 6789101112 Next page Last page
A service from the Financial Times